Long-Term Anticoagulation in Secondary Ischemic Stroke Prevention: The Prospective Multicenter RESTAIC Registry

Background and Objective: Oral anticoagulation (OAC) for secondary stroke prevention is recommended in atrial fibrillation (AF) and other sources of cardioembolic stroke. Our objectives were to explore the differences in ischemic and hemorrhagic events when using OAC for secondary stroke prevention...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Front Neurol
Autori principali: Gutiérrez-Zúñiga, Raquel, Rigual, Ricardo, Torres-Iglesias, Gabriel, Sánchez-Velasco, Sara, Alonso de Leciñana, María, Masjuan, Jaime, Álvarez Velasco, Rodrigo, Navas, Inmaculada, Izquierdo-Esteban, Laura, Fernández-Ferro, José, Rodríguez-Pardo, Jorge, Ruiz-Ares, Gerardo, Zapata-Wainberg, Gustavo, Fuentes, Blanca, Díez-Tejedor, Exuperio
Natura: Artigo
Lingua:Inglês
Pubblicazione: Frontiers Media S.A. 2020
Soggetti:
Neurology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7641639/
https://ncbi.nlm.nih.gov/pubmed/33193025
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2020.575634
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi